Rigaku - Public Comps and Valuation Multiples

Rigaku Overview

About Rigaku

Rigaku Holdings Corp is engaged in manufacturing and sales of scientific instruments focused on X-ray technologies.

Founded

2020

HQ

Employees

n/a

Website

rigaku-holdings.com

Sectors

Medical Devices

Financials

LTM Revenue $613M

LTM EBITDA $159M

EV

$1.4B

Valuation Multiples

Multiples.vc

Valuation Multiples for 10K+ Public Comps

Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.

Browse Valuation Multiples

Rigaku Financials

Rigaku has a last 12-month revenue of $613M and a last 12-month EBITDA of $159M.

In the most recent fiscal year, Rigaku achieved revenue of $602M and an EBITDA of $157M.

Rigaku expects next 12-month revenue of XXX and NTM EBITDA of XXX

See Rigaku valuation multiples based on analyst estimates

Rigaku P&L

	FY 2023	FY 2024	FY 2025	LTM	NTM
Revenue	$531M	$602M	XXX	XXX	XXX
Gross Profit	$251M	$310M	XXX	XXX	XXX
Gross Margin	47%	51%	XXX	XXX	XXX
EBITDA	$132M	$157M	XXX	XXX	XXX
EBITDA Margin	25%	26%	XXX	XXX	XXX
Net Profit	$6.1M	$72.5M	XXX	XXX	XXX
Net Margin	1%	12%	XXX	XXX	XXX
Net Debt	$303M	$240M	XXX	XXX	XXX

Financial data powered by Morningstar, Inc.

Rigaku Stock Performance

As of April 15, 2025, Rigaku's stock price is JPY 788 (or $5).

Rigaku has current market cap of JPY 177B (or $1.2B), and EV of JPY 211B (or $1.4B).

See Rigaku trading valuation data

Rigaku Stock Data

EV	Market Cap	Price 1D	Price 1M	Price 3M	Price 12M	EPS
$1.4B	$1.2B	XXX	XXX	XXX	XXX	$0.40

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more

Rigaku Valuation Multiples

As of April 15, 2025, Rigaku has market cap of $1.2B and EV of $1.4B.

Rigaku's trades at 2.3x LTM EV/Revenue multiple, and 8.8x LTM EBITDA.

Analysts estimate Rigaku's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX

See valuation multiples for Rigaku and 10K+ public comps

Rigaku Financial Valuation Multiples

	FY 2024	FY 2025E	FY 2026E	FY 2027E
EV	$1.4B	XXX	XXX	XXX
EV/Revenue	2.3x	XXX	XXX	XXX
EV/EBITDA	8.9x	XXX	XXX	XXX
P/E	13.0x	XXX	XXX	XXX
P/E/Growth	1.6x	XXX	XXX	XXX
EV/FCF	25.6x	XXX	XXX	XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Get Rigaku Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.

Rigaku Valuation Multiples

Rigaku's NTM/LTM revenue growth is 7%

Rigaku's revenue per employee for the last fiscal year averaged n/a, while opex per employee averaged n/a for the same period.

Over next 12 months, Rigaku's ratio of sales and marketing spend to revenue is estimated to be XXX , while its R&D spend to revenue to be XXX .

Analysts estimate Rigaku's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX

See operational valuation multiples for Rigaku and other 10K+ public comps

Rigaku Operational Valuation Multiples

	FY 2024	NTM	FY 2025E	FY 2026E	FY 2027E
Revenue Growth	13%	XXX	XXX	XXX	XXX
EBITDA Margin	26%	XXX	XXX	XXX	XXX
EBITDA Growth	19%	XXX	XXX	XXX	XXX
Rule of 40 (SaaS-only)	33%	XXX	XXX	XXX	XXX
Revenue per Employee	n/a	XXX	XXX	XXX	XXX
Opex per Employee	n/a	XXX	XXX	XXX	XXX
S&M Expenses to Revenue	n/a	XXX	XXX	XXX	XXX
G&A Expenses to Revenue	41%	XXX	XXX	XXX	XXX
R&D Expenses to Revenue	n/a	XXX	XXX	XXX	XXX
Opex to Revenue	41%	XXX	XXX	XXX	XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 220+ Verticals

Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!

Digital Therapeutics

Pharma Analytics

Private Equity

ERP Software

Developer Tools

Consumer SaaS

Streaming Platforms

Explore Valuation Multiples by Industry